Close Menu

NEW YORK (GenomeWeb) – Roche reported on Thursday a 6 percent increase in revenues from its Diagnostics division for the first half of 2016, driven by strong growth of all diagnostics businesses except diabetes care.

In total, the Swiss pharmaceutical and diagnostics company reported CHF 25.02 billion ($25.5 billion) in half-year sales, a 6 percent increase compared to half-year sales of CHF 23.59 billion in 2015. On a constant currency basis, total sales grew 5 percent in the first half of 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
23
Sponsored by
Qiagen

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.